Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Plasma cell 2Other solid neoplasm 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Pleural Mesothelial Neoplasm 1

Interventions

pembrolizumab 159Carboplatin 147Cisplatin 130Pemetrexed 103Paclitaxel 89Nivolumab 71Radiotherapy 69Docetaxel 62Erlotinib Hydrochloride 58Gemcitabine 57Etoposide 44osimertinib 43Bevacizumab 43Cyclophosphamide 42durvalumab 41atezolizumab 35Cetuximab 33Radiosurgery 26130-nm albumin-bound paclitaxel 26fludarabine 23Ipilimumab 23Radiation 21Magnetic Resonance Spectroscopy 21Irinotecan 21Taxes 20Oxaliplatin 20Fluorouracil 20Gefitinib 19Everolimus 19Topotecan 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Adjuvants, Immunologic × Thoracic × Clear all
NCT04926948 2025-10-22

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

Mayo Clinic

Phase 1 Active not recruiting
20 enrolled
Thoracic

Pleural Mesothelial Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡